002390 信邦制药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.7141.7821.4954.2053.342
总资产报酬率 ROA (%)0.5671.3651.1103.0172.310
投入资产回报率 ROIC (%)0.6491.5731.2883.4972.672

边际利润分析
销售毛利率 (%)16.20217.64817.17319.01619.165
营业利润率 (%)6.0014.2224.2255.9594.981
息税前利润/营业总收入 (%)6.2504.3143.3506.5595.549
净利润/营业总收入 (%)5.1103.4132.5815.4764.224

收益指标分析
经营活动净收益/利润总额(%)94.676140.936172.391108.803106.719
价值变动净收益/利润总额(%)1.3578.5841.5782.37311.942
营业外收支净额/利润总额(%)0.599-3.180-37.3832.775-0.935

偿债能力分析
流动比率 (X)3.5013.3082.9072.6292.161
速动比率 (X)2.8952.6932.3202.1431.777
资产负债率 (%)17.06418.07522.24622.74627.861
带息债务/全部投入资本 (%)8.0238.83213.32313.26919.180
股东权益/带息债务 (%)1,137.6341,024.492646.603649.425418.799
股东权益/负债合计 (%)467.958437.295334.097325.857249.518
利息保障倍数 (X)29.40119.47112.17315.2699.040

营运能力分析
应收账款周转天数 (天)166.478155.767161.420161.257164.537
存货周转天数 (天)74.07276.29974.25769.95669.026